Synthetic Biologics, Inc. (SYN)
R&D Expense Growth
-28.48%
Fiscal year · Period ending:
SYN R&D Expense Growth
Latest reported-28.48%period ending
Latest reported-28.48%period ending
SYN FY R&D Growth (YoY) (0.00% → -28.48%)
Latest values, visible window
High-resolution chart · PNG
SYN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -28.4847% | |
| 0% | |
| 50.2949% | |
| 52.0172% | |
| -53.7039% | |
| -6.4252% | |
| -36.9463% | |
| -35.4701% | |
| -11.5389% | |
| 127.1102% | |
| 122.6679% | |
| -47.0416% | |
| 267.8743% | |
| 111.407% | |
| 31.2278% | |
| -74.0732% | |
| -26.6155% | |
| 137.3887% | |
| 181.7518% | |
| 0% | |
| -100% | |
| -39.623% | |
| 60.1012% | |
| 9.5187% | |
| 42.5723% | |
| -55.5556% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| -100% | |
| 0% |